DescriptionMedexus Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on auto-immune and pediatric diseases in the USA and Canada. The company's only reportable segment being the products sold and the marketing services offered to the pharmaceutical industry. Geographically, it derives a majority of revenue from the United States. Its product portfolio includes Rasuvo, Metoject, Rupall, Gliolan, and Treosulfan.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 6.890 +0.87% increase |
| 7.750 -10.32% decrease |
| -0.350 (-4.79%) decrease |
|3-Month|| 6.550 +6.11% increase |
| 8.800 -21.02% decrease |
| -1.820 (-20.75%) decrease |
|52-Week|| 2.390 +190.79% increase |
| 9.750 -28.72% decrease |
| +4.200 (+152.73%) increase |